I agree and think that price target is very obtainable. Well they say regenerative medicine is a 15 billion industry already and rapidly growing. I think $100m market cap could EASILY be achieved IF we get the IP acceptance and I think that might be a bit on the low side considering how SVFC's extraction process is far superior than other companies. Even if all 3.5 billion shares were trading in the open market (I highly doubt they are going to right away dump all 2 billion into the market - I think they are saving some of it for a partnership deal down the line) they would put the pps at approximately .03 per share.
I still think the MJ stocks are more a fade right now and based solely on hype. EVEN if they could produce huge revenues, which I think that is a bit of stretch considering there are TONS of a companies out there selling it, I don't think they are worth of billion dollar market caps (which I believe a lot of them are valued at right now). There is no market entry barrier - anybody can start growing mj and get approved to sell it (not that hard).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.